4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000003
Chief Commercial Officer gave up 725 shares (to pay taxes)
- Chief Commercial Officer acquired 2,068 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Poddar Richa Chief Commercial Officer | 2022-02-10 | Option exercise | +2,068 | 2,218 | D: show line 1 in the form | ||
| Poddar Richa Chief Commercial Officer | 2022-02-10 | Shares withheld for taxes | −725 | $31.43 | $22,783 | 1,493 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Poddar Richa Chief Commercial Officer | 2022-02-10 | Option exercise · Restricted stock units | −2,068 | 4,136 | D: show line 3 in the form |
Loading xslF345X03/wf-form4_164487275264401.xml…